𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis

✍ Scribed by Tolomeo, Manlio; Dusonchet, Luisa; Meli, Maria; Grimaudo, Stefania; D'Alessandro, Natale; Papoff, Giuliana; Ruberti, Giovina; Rausa, Luciano

Book ID
110015811
Publisher
Nature Publishing Group
Year
1998
Tongue
English
Weight
249 KB
Volume
5
Category
Article
ISSN
1350-9047

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Resistance to CD95-mediated apoptosis in
Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene
✍ Markus MΓΌschen; Daniel Re; Beate Betz; Cordula Moers; JΓΌrgen Wolf; Dieter Nieder πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 45 KB πŸ‘ 2 views

Resistance to CD95 (Apo-1/Fas)-mediated apoptosis is a typical feature of breast cancer cells. Recent studies identified deleterious mutations of the CD95 gene not only in a variety of B cell lymphomas but also in a number of solid tumor entities. Therefore, we amplified and sequenced selected regio

Drug-induced apoptosis in osteosarcoma c
Drug-induced apoptosis in osteosarcoma cell lines is mediated by caspase activation independent of CD95-receptor/ligand interaction
✍ J. Fellenberg; H. Mau; S. Nedel; V. Ewerbeck; K-M. Debatin πŸ“‚ Article πŸ“… 2000 πŸ› Elsevier Science 🌐 English βš– 782 KB

## Abstract Osteosarcoma is one of the most common primary malignant tumors of bone. Treatment of this tumor with systemic chemotherapy dramatically improves the prognosis, although the molecular mechanisms involved in the drug action are poorly understood. In chemosensitive leukaemic T cells and c